Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 04:00PM ET
14.44
Dollar change
+0.02
Percentage change
0.14
%
IndexRUT P/E- EPS (ttm)-2.57 Insider Own4.93% Shs Outstand36.36M Perf Week4.26%
Market Cap525.62M Forward P/E- EPS next Y-2.20 Insider Trans0.00% Shs Float34.60M Perf Month-2.56%
Income-92.21M PEG- EPS next Q-1.05 Inst Own105.42% Short Float12.11% Perf Quarter-35.28%
Sales425.17M P/S1.24 EPS this Y-3.61% Inst Trans-1.54% Short Ratio8.67 Perf Half Y-24.52%
Book/sh8.06 P/B1.79 EPS next Y16.87% ROA-14.90% Short Interest4.19M Perf Year-56.24%
Cash/sh8.87 P/C1.63 EPS next 5Y- ROE-29.89% 52W Range13.36 - 39.67 Perf YTD-32.90%
Dividend Est.- P/FCF- EPS past 5Y-9.37% ROI-18.11% 52W High-63.60% Beta0.89
Dividend TTM- Quick Ratio4.94 Sales past 5Y2.57% Gross Margin65.57% 52W Low8.08% ATR (14)0.73
Dividend Ex-Date- Current Ratio6.37 EPS Y/Y TTM-3521.97% Oper. Margin-23.36% RSI (14)46.61 Volatility3.70% 4.98%
Employees1215 Debt/Eq0.76 Sales Y/Y TTM4.63% Profit Margin-21.69% Recom3.28 Target Price19.00
Option/ShortYes / Yes LT Debt/Eq0.74 EPS Q/Q54.23% Payout0.00% Rel Volume0.69 Prev Close14.42
Sales Surprise3.48% EPS Surprise48.91% Sales Q/Q2.05% EarningsFeb 21 AMC Avg Volume483.33K Price14.44
SMA201.32% SMA50-9.58% SMA200-24.28% Trades Volume332,027 Change0.14%
Date Action Analyst Rating Change Price Target Change
Feb-22-24Downgrade Oppenheimer Outperform → Perform
Jan-12-24Downgrade RBC Capital Mkts Outperform → Sector Perform $23 → $20
Dec-21-23Downgrade Canaccord Genuity Buy → Hold $23
Jul-19-23Initiated Robert W. Baird Neutral $26
May-31-23Initiated RBC Capital Mkts Outperform $40
May-15-23Upgrade Oppenheimer Perform → Outperform $40
Apr-14-23Initiated Mizuho Neutral $40
Jan-17-23Downgrade Citigroup Buy → Neutral $40
Jan-06-23Downgrade Piper Sandler Neutral → Underweight $42 → $38
Dec-20-22Upgrade Canaccord Genuity Hold → Buy $41 → $67
Mar-21-24 12:35PM
Feb-29-24 07:29AM
Feb-28-24 04:10PM
Feb-22-24 06:21PM
11:20AM
10:50AM Loading…
10:50AM
06:40AM
Feb-21-24 05:20PM
04:43PM
04:21PM
04:06PM
04:05PM
Feb-14-24 10:00AM
Feb-01-24 04:30PM
Jan-29-24 04:30PM
05:00AM Loading…
Jan-22-24 05:00AM
Jan-19-24 10:48AM
Jan-18-24 04:15PM
Jan-17-24 04:15PM
Jan-14-24 05:28PM
Jan-10-24 09:41AM
12:43AM
Jan-09-24 08:30AM
Jan-04-24 04:15PM
Dec-26-23 11:45AM
Dec-12-23 06:56AM
Dec-04-23 06:07AM
Dec-01-23 11:31AM
11:16AM
Nov-30-23 05:19PM
09:55AM Loading…
Nov-23-23 09:55AM
Nov-21-23 09:14AM
Nov-20-23 07:00AM
Nov-02-23 06:33PM
12:16PM
08:33AM
Nov-01-23 07:29PM
04:26PM
04:01PM
Oct-25-23 10:02AM
Oct-04-23 07:00AM
Sep-18-23 07:00AM
02:23AM
Aug-23-23 07:00AM
Aug-18-23 01:01PM
Aug-16-23 07:00AM
Aug-15-23 10:32AM
Aug-10-23 04:52AM
Aug-02-23 03:40PM
11:28AM
Aug-01-23 05:45PM
04:40PM
04:03PM
Jul-31-23 09:43AM
Jul-27-23 09:15AM
Jul-13-23 07:00AM
Jul-12-23 07:00AM
Jun-27-23 07:00AM
Jun-23-23 07:00AM
Jun-19-23 10:27AM
Jun-07-23 08:04AM
Jun-05-23 04:05PM
Jun-02-23 11:31AM
May-22-23 07:00AM
May-18-23 06:52AM
Apr-27-23 04:05PM
10:57AM
09:32AM
Apr-26-23 05:45PM
04:40PM
04:05PM
Apr-25-23 01:38PM
11:40AM
09:55AM
Apr-24-23 05:03PM
10:00AM
07:00AM
Apr-20-23 12:07PM
Apr-19-23 05:05PM
Apr-18-23 03:06PM
Mar-29-23 07:00AM
Mar-09-23 10:24AM
Mar-07-23 07:00AM
Feb-23-23 04:05PM
Feb-19-23 07:15AM
Feb-17-23 11:06AM
07:51AM
Feb-16-23 05:55PM
04:05PM
Feb-14-23 10:00AM
Feb-13-23 09:11AM
Feb-09-23 10:01AM
Feb-03-23 06:35AM
Feb-01-23 07:00AM
Jan-31-23 04:05PM
08:54AM
Jan-19-23 07:00AM
Jan-12-23 07:00AM
Jan-11-23 11:56AM
Jan-09-23 06:00AM
Nevro Corp. engages in the development of medical devices. The firm focuses on providing products that improve the quality of life of patients suffering from debilitating chronic pain. It develops and commercializes the senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain. The company was founded by Konstantinos Alataris in March 2006 and is headquartered in Redwood City, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
McCormick ShawnDirectorJun 07 '23Buy22.887,500171,63326,866Jun 09 04:37 PM
DEMANE MICHAEL FDirectorApr 12 '23Option Exercise18.0080,2911,445,238101,018Apr 14 04:22 PM